Moderna Stock (MRNA): Inside the Phase 3 Cancer Vaccine Win 1. Introduction On 19 August 2026, Moderna closed up 176.97% at $174.38. It was the best day in the company’s history and the largest single-session gain in the S&P 500 that day, adding roughly $45 billion of market value in a few hours. The catalyst…
Read more
Why Novo Nordisk (NVO) Just Cut Prices by 50% The global pharmaceutical landscape is currently navigating a period of profound structural transformation, centered on the evolution of cardiometabolic medicine. At the forefront of this shift is Novo Nordisk, a centenarian institution that has transitioned from a niche provider of bovine insulin to a multi-trillion-dollar arbiter…
Read more
Hims & Hers (HIMS): The “Netflix of Medicine” Just Hit Escape Velocity 1. Introduction: The Pill is Just the Pixel For years, Wall Street debated whether Hims & Hers Health (HIMS) was a technology company or just a glorified online pharmacy. The skeptics argued it was a “commoditized middleman” selling generic Viagra and hair loss…
Read more